RETINA-AI Health, Inc is a cutting-edge healthcare technology company based in Houston, TX. They have developed the RETINA-AI Galaxy, an advanced artificial intelligence system that provides immediate and fully-automated diabetic retinopathy screening in the primary care setting, with diagnosis results in less than 10 seconds. This innovative technology eliminates the need for human graders and on-site eyecare specialists, making it fast, efficient, and accessible for patients. RETINA-AI's goal is to prevent blindness caused by diabetic retinopathy through early detection and treatment, and their system works with multiple cameras, is easy to use, and has FDA clearance pending.
With the RETINA-AI Galaxy, primary care providers can add a new revenue stream and improve HEDIS measures and CMS Star Ratings. The system is designed to save costs and reduce payouts by closing care gaps and preventing blindness, while enabling providers to triage patients at the point-of-care. RETINA-AI's technology is the most technologically advanced in the market, with multi-camera compatibility and a robotic camera option that requires no manual adjustments. It is backed by clinical trials and offers easy training for any medical assistant, without the need for prior ophthalmic experience. The diagnostic reports generated by the RETINA-AI Galaxy are easy to understand and aligned with the American Academy of Ophthalmology guidelines.
Generated from the website